European medicine supply: Access in the spotlight
Drug shortages, created by consolidation of manufacturing and pricing policy, a ‘growing concern’, the EFPIA suggests.
Archives for September 25, 2019
A-Alpha Bio raises $2.8m to solve ‘major problems’ in early-stage drug development: CEO
A-Alpha Bio raises $2.8m from venture capital firms and angel investors to further develop its technology – and initiate drug discovery and optimization partnerships with pharmaceutical companies.